212 related articles for article (PubMed ID: 33783856)
41. Double Filtration Plasmapheresis in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Dysfunction.
Cheng L; Tang YQ; Yi J; Ren Q; Yang XY; Gou SJ; Zhang L; Fu P
Blood Purif; 2020; 49(6):713-722. PubMed ID: 32294643
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of different low-density lipoprotein apheresis methods.
Parhofer KG; Geiss HC; Schwandt P
Ther Apher; 2000 Oct; 4(5):382-5. PubMed ID: 11111821
[TBL] [Abstract][Full Text] [Related]
43. Taking therapeutic apheresis services to patients in South Africa: An eight year review of SANBS mobile therapeutic apheresis service, 2013-2020.
Poole C; Strydom C; van der Berg K; Vrielink H
Transfus Apher Sci; 2021 Jun; 60(3):103167. PubMed ID: 34116933
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic apheresis in kidney diseases: an updated review.
Chen YY; Sun X; Huang W; He FF; Zhang C
Ren Fail; 2022 Dec; 44(1):842-857. PubMed ID: 35723077
[TBL] [Abstract][Full Text] [Related]
45. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Lyu RK; Chen WH; Hsieh ST
Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
[TBL] [Abstract][Full Text] [Related]
46. Practical considerations for planning a therapeutic apheresis procedure.
Shelat SG
Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
[TBL] [Abstract][Full Text] [Related]
47. Therapeutic Plasmapheresis: A Revision of Literature.
Altobelli C; Anastasio P; Cerrone A; Signoriello E; Lus G; Pluvio C; Perna AF; Capasso G; Simeoni M; Capolongo G
Kidney Blood Press Res; 2023; 48(1):66-78. PubMed ID: 36481657
[TBL] [Abstract][Full Text] [Related]
48. Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case report.
Gauckler P; Leierer J; Kocher F; Feistritzer C; Willenbacher W; Gunsilius E; Wolf D; Neuwirt H; Mayer G; Kronbichler A
J Clin Apher; 2020 Jun; 35(3):227-230. PubMed ID: 32142176
[TBL] [Abstract][Full Text] [Related]
49. [Is apheresis still a useful tool in the treatment of nephrological diseases?].
Santoro A
G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983168
[TBL] [Abstract][Full Text] [Related]
50. The effect of immunoadsorption with the Immusorba TR-350 column on coagulation compared to plasma exchange.
Koessler J; Kobsar A; Kuhn S; Koessler A; Yilmaz P; Weinig E; Putz E; Boeck M; Klinker E
Vox Sang; 2015 Jan; 108(1):46-51. PubMed ID: 25131310
[TBL] [Abstract][Full Text] [Related]
51. Lipidfiltration--safe and effective methodology to perform lipid-apheresis.
Klingel R; Mausfeld P; Fassbender C; Goehlen B
Transfus Apher Sci; 2004 Jun; 30(3):245-54. PubMed ID: 15172630
[TBL] [Abstract][Full Text] [Related]
52. Double filtration plasmapheresis in critical care.
Mineshima M; Akiba T
Ther Apher; 2002 Jun; 6(3):180-3. PubMed ID: 12109939
[TBL] [Abstract][Full Text] [Related]
53. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Tagawa Y; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
[TBL] [Abstract][Full Text] [Related]
54. From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis.
Klingel R; Fassbender T; Fassbender C; Göhlen B
Ther Apher Dial; 2003 Jun; 7(3):350-8. PubMed ID: 12924612
[TBL] [Abstract][Full Text] [Related]
55. How to improve clotting factors depletion in double-filtration plasmapheresis.
Naciri Bennani H; Marlu R; Terrec F; Motte L; Seyve L; Chevallier E; Malvezzi P; Jouve T; Rostaing L; Noble J
J Clin Apher; 2021 Oct; 36(5):766-774. PubMed ID: 34339059
[TBL] [Abstract][Full Text] [Related]
56. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
57. Apheresis in treatment of acute inflammatory demyelinating disorders.
Mühlhausen J; Kitze B; Huppke P; Müller GA; Koziolek MJ
Atheroscler Suppl; 2015 May; 18():251-6. PubMed ID: 25936333
[TBL] [Abstract][Full Text] [Related]
58. Regional Citrate Anticoagulation during Double-Filtration Plasmapheresis in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study.
Ho QY; Teh SP; Thangaraju S; Teo SH; Tan HK; Abdul Rahman MB; Ng LC; Lim AEL; Choong LHL; Kee T; Kaushik M;
Blood Purif; 2022; 51(4):376-382. PubMed ID: 34198288
[TBL] [Abstract][Full Text] [Related]
59. Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
Julius U; Metzler W; Pietzsch J; Fassbender T; Klingel R
Int J Artif Organs; 2002 Dec; 25(12):1180-8. PubMed ID: 12518963
[TBL] [Abstract][Full Text] [Related]
60. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]